XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements Of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net income (loss) $ (61,195,000) $ (87,589,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 886,000 2,040,000
Noncash lease expense 649,000 815,000
Pay-to-Play financing charge 0 35,832,000
Debt financing charge on convertible notes 464,000 3,145,000
Stock-based compensation 3,847,000 2,483,000
Credit loss expense 570,000 421,000
Deferred income taxes (1,124,000) (107,000)
Change in fair value of convertible notes 10,022,000 9,532,000
Change in fair value of warrant liabilities 5,701,000 945,000
Loss on purchase commitments 0 1,165,000
Non-cash loss on lease termination 0 (18,000)
Changes in operating assets and liabilities:    
Accounts receivable (614,000) 362,000
Accounts receivable – related party 467,000 639,000
Inventories (2,039,000) (2,186,000)
Prepaid expenses and other current assets (21,630,000) 167,000
Other assets 15,000 64,000
Accounts payable and accrued liabilities 10,988,000 9,500,000
Operating lease liabilities (616,000) (854,000)
Income tax payable 2,108,000 (590,000)
Accrued loss on purchase commitments (2,985,000) (3,022,000)
Accrued compensation (325,000) 34,000
Other liabilities 1,279,000 (733,000)
Net cash used in operating activities (53,532,000) (27,955,000)
Cash flows from investing activities:    
Purchases of property and equipment (902,000) (220,000)
Net cash provided by investing activities (902,000) (220,000)
Cash flows from financing activities:    
Payment of deferred offering costs (4,357,000) 0
Proceeds from convertible promissory note - related party 110,718,000 12,300,000
Proceeds from short term demand notes 0 4,925,000
Repayment of short term demand notes (4,750,000) (176,000)
Proceeds from exercise of stock options 98,000 1,000
Net cash provided by (used in) financing activities 101,709,000 26,475,000
Net increase (decrease) in cash, cash equivalents and restricted cash 47,275,000 (1,700,000)
Cash and restricted cash – beginning of period 3,213,000 4,913,000
Cash and restricted cash - end of period 50,488,000 3,213,000
Supplemental cash flow disclosures;    
Cash paid during the year for interest 245,000 3,000
Cash paid for income taxes 223,000 0
Supplemental disclosure of non-cash investing and financing activities:    
Property and equipment acquired in accounts payable & accrued expenses 510,000 0
Reissuance of Shadow Preferred in Pay-to-Play Pull Through Exchange at redemption value 0 109,327,000
Operating lease asset obtained in exchange for new operating lease liabilities 0 1,673,000
Right-of-use assets and lease liabilities extinguished upon termination of lease, net of gain 0 (108,000)
Capitalized deferred offering costs included in accounting payable and accrued liabilities 6,764,000 1,491,000
Issuance of warrants with convertible notes 4,816,000 1,690,000
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]    
Cash - beginning of period 3,213,000  
Cash and restricted cash – beginning of period 3,213,000 4,913,000
Cash - end of period 50,237,000 3,213,000
Restricted cash - end of period 251,000 0
Cash and restricted cash - end of period 50,488,000 3,213,000
Pay-to-Play convertible notes and Common Rights Offering    
Cash flows from financing activities:    
Proceeds from convertible promissory note - related party 0 9,425,000
BURTECH ACQUISITION CORP.    
Cash flows from operating activities:    
Net income (loss) (4,113,532) 1,339,142
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest earned on cash and investments held in Trust Account (2,465,138) (5,751,596)
Change in fair value of derivative liability - Backstop Subscription Agreement 1,084,963 0
Penalties and interest on excise taxes 310,728 0
Changes in operating assets and liabilities:    
Accrued expenses 2,722,517 1,618,895
Franchise tax payable 200,000 35,800
Prepaid expenses and other current assets 0 186,532
Income tax payable (510,465) 235,886
Net cash used in operating activities (2,770,927) (2,335,341)
Cash flows from investing activities:    
Cash withdrawn from Trust Account used to pay franchise and income taxes 664,839 1,314,246
Principal deposits into Trust Account for Extension (1,639,296) (130,370)
Restricted Cash 0 843,313
Due from Sponsor 0 318,888
Cash withdrawn from Trust Account in connection with redemptions 2,774,658 227,776,035
Net cash provided by investing activities 1,800,201 230,122,112
Cash flows from financing activities:    
Proceeds from Advances from sponsor 2,971,258 0
Proceeds from convertible promissory note - related party 689,655 810,345
Redemptions of Common Stock (2,774,658) (227,776,035)
Net cash provided by (used in) financing activities 886,255 (226,965,690)
Net increase (decrease) in cash, cash equivalents and restricted cash (84,471) 821,081
Cash and restricted cash – beginning of period 843,313 22,232
Cash and restricted cash - end of period 758,842 843,313
Supplemental cash flow disclosures;    
Cash paid for income taxes 1,027,644 791,758
Supplemental disclosure of non-cash investing and financing activities:    
Excise tax liability arising from redemption of Class A shares 27,747 2,523,150
Accretion of Class A common stock subject to possible redemption 3,380,995 4,510,051
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]    
Cash - beginning of period 0 22,232
Restricted cash – beginning of period 843,313  
Cash and restricted cash – beginning of period 843,313 22,232
Cash - end of period 1,506 0
Restricted cash - end of period 757,336 843,313
Cash and restricted cash - end of period $ 758,842 $ 843,313